Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
Clinical trial NCT04713592 · COMPLETED
Trial details
- NCT number
- NCT04713592
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-26
- Primary completion
- 2023-04-20
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.